Cassava Stock Analysis

SAVA
 Stock
  

USD 46.18  0.99  2.19%   

The current price rise of Cassava Sciences created some momentum for investors as it was traded today as low as 43.32 and as high as 46.89 per share. The company executives may have good odds in positioning the firm resources to exploit market volatility in October. The stock standard deviation of daily returns for 90 days investing horizon is currently 8.87. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Cassava Sciences partners.
Additionally, take a look at World Market Map.
  
The Cassava Sciences stock analysis report makes it easy to digest most publicly released information about Cassava Sciences and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Cassava Stock analysis module also helps to analyze the Cassava Sciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Cassava Stock Analysis Notes

About 26.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.3. Cassava Sciences last dividend was issued on the 13th of December 2012. The entity had a split on the 10th of May 2017. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Cassava Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people. To find out more about Cassava Sciences contact Remi Barbier at 512 501 2444 or learn more at https://www.cassavasciences.com.

Cassava Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Cassava Sciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Cassava Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Cassava Sciences is way too risky over 90 days horizon
Cassava Sciences appears to be risky and price may revert if volatility continues
Cassava Sciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (46.39 M) with loss before overhead, payroll, taxes, and interest of (24.81 M).
Cassava Sciences currently holds about 209.69 M in cash with (51.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.23.
Latest headline from www.investors.com: SAVA Stock Dives After Refuting New Claims Around Its Data Tampering Case - Investors Business Daily

Cassava Sciences Upcoming and Recent Events

Earnings reports are used by Cassava Sciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cassava Sciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report22nd of March 2022
Next Financial Report20th of April 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End22nd of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Cassava Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.85 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cassava Sciences's market, we take the total number of its shares issued and multiply it by Cassava Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (11.16) % which means that it has lost $11.16 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (17.9) %, meaning that it created substantial loss on money invested by shareholders. Cassava Sciences management efficiency ratios could be used to measure how well cassava sciences manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 27th of September, Cassava Sciences shows the Risk Adjusted Performance of 0.1307, mean deviation of 5.64, and Downside Deviation of 5.88. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cassava Sciences, as well as the relationship between them. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Cassava Sciences, which can be compared to its rivals. Please confirm Cassava Sciences jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Cassava Sciences is priced correctly, providing market reflects its regular price of 46.18 per share. Given that Cassava Sciences has jensen alpha of 0.9008, we suggest you to validate Cassava Sciences's prevailing market performance to make sure the company can sustain itself at a future point.

Cassava Sciences Price Movement Analysis

The output start index for this execution was thirty-four with a total number of output elements of twenty-seven. The Weighted Moving Average calculates a weight for each value in Cassava Sciences price series with the more recent values given greater weights.
.

Cassava Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cassava Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cassava Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cassava Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sanford Robertson over two weeks ago via Macroaxis 
Exercise or conversion by Sanford Robertson of 2802 shares of Cassava Sciences subject to Rule 16b-3
Barry Richard over a month ago via Macroaxis 
Purchase by Barry Richard of 36159 shares of Cassava Sciences
Kupiec James William over a month ago via Macroaxis 
Purchase by Kupiec James William of 2500 shares of Cassava Sciences
Eric Schoen over a month ago via Macroaxis 
Cassava Sciences exotic insider transaction detected
Remi Barbier over three months ago via Macroaxis 
Exercise or conversion by Remi Barbier of 65368 shares of Cassava Sciences subject to Rule 16b-3
Remi Barbier over three months ago via Macroaxis 
Exercise or conversion by Remi Barbier of 65368 shares of Cassava Sciences subject to Rule 16b-3
Robert Gussin over six months ago via Macroaxis 
Exercise or conversion by Robert Gussin of 2801 shares of Cassava Sciences subject to Rule 16b-3
Sanford Robertson over six months ago via Macroaxis 
Exercise or conversion by Sanford Robertson of 4670 shares of Cassava Sciences subject to Rule 16b-3
Remi Barbier over six months ago via Macroaxis 
Purchase by Remi Barbier of 10000 shares of Cassava Sciences
Remi Barbier over six months ago via Macroaxis 
Exercise or conversion by Remi Barbier of 56030 shares of Cassava Sciences subject to Rule 16b-3
Armistice Capital Llc over six months ago via Macroaxis 
Cassava Sciences exotic insider transaction detected
Robert Gussin over a year ago via Macroaxis 
Exercise or conversion by Robert Gussin of 2801 shares of Cassava Sciences subject to Rule 16b-3

Cassava Sciences Predictive Daily Indicators

Cassava Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cassava Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Cassava Sciences Forecast Models

Cassava Sciences time-series forecasting models is one of many Cassava Sciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cassava Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Cassava Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cassava Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cassava shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Cassava Sciences. By using and applying Cassava Stock analysis, traders can create a robust methodology for identifying Cassava entry and exit points for their positions.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial and investigational diagnostic product candidate is SavaDx, a blood-based biomarkerdiagnostic to detect Alzheimers disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.

Current Cassava Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cassava analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cassava analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
140.67Strong Buy3Odds
Cassava Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Cassava analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Cassava stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Cassava Sciences, talking to its executives and customers, or listening to Cassava conference calls.
Cassava Analyst Advice Details

Cassava Stock Analysis Indicators

Cassava Sciences stock analysis indicators help investors evaluate how Cassava Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cassava Sciences shares will generate the highest return on investment. By understating and applying Cassava Sciences stock analysis, traders can identify Cassava Sciences position entry and exit signals to maximize returns.
Quick Ratio30.89
Fifty Two Week Low13.84
Shares Short Prior Month10.97M
Average Daily Volume Last 10 Day6.79M
Average Daily Volume In Three Month3.47M
Shares Percent Shares Out25.40%
Short Percent Of Float26.91%
Forward Price Earnings-36.08
Float Shares37.48M
Fifty Two Week High100.00
Enterprise Value To Ebitda-9.61
Fifty Day Average26.19
Two Hundred Day Average32.25
Additionally, take a look at World Market Map. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for analysis

When running Cassava Sciences price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Is Cassava Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Cassava Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.